StockData
Aquestive Therapeutics, Inc. logo

Aquestive Therapeutics, Inc. (AQST) stock

AQSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 3/30
$3.70−0.06 (-1.60%)

Close on Nov 17, 2026Market cap $464.39MP/E –Yield –

Aquestive Therapeutics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Aquestive Therapeutics's EV/EBITDA was 20.2× on Jan 31, 2019.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2019Jan 31, 201920.2×−1.0
2018Dec 31, 201821.1×–

More Aquestive Therapeutics figures

See a number that looks wrong?